Proto Labs shares fell 11.3% on 2026-10-30, closing at $68.89 from a previous close of $77.64, even though the company beat consensus on both revenue and profit and raised its full-year guidance. A report tied the slide to higher raw material costs squeezing margins, an explanation that fits part of what the company reported but not all of it: GAAP operating margin widened over the quarter while gross margin narrowed.
A record quarter on revenue and profit
Third-quarter revenue reached a record $154.3 million, up 14.0% from a year earlier, Protolabs said in its results announcement. GAAP diluted earnings rose to 0.48 a share from 0.30 in the third quarter of 2025, up 60.0% year over year. Non-GAAP earnings of 0.63 a share beat the average analyst estimate of 0.60 by 5.7%. Net income rose 63.0% to $11.8 million, and GAAP operating margin was up 2.8 percentage points year on year to 9.4%, from 6.5% in the same quarter last year. The company raised its full-year revenue growth guidance from 8.0%−10.0% to 10.0%−11.0% and guided to fourth-quarter revenue of $143.0 million to $151.0 million, with GAAP diluted earnings per share of $0.28 to $0.36.
Underneath that improvement sat the one line that moved the other way: GAAP gross margin fell 0.8 percentage points to 44.5%, from 45.3% a year earlier.
A reaction several times the usual size
The decline was 3.6x Proto Labs' typical daily move over the past year, which has averaged 3.1%, and shares traded on volume 2.4x the 30-day average. By comparison, the S&P 500 fell 1.8% on the same session, and the median move among other covered industrial machinery, supplies and components companies was down 2.5%, which points to a company-specific reaction rather than a market-wide one.
Why the beat didn't stop the slide
One report attributed the fall specifically to "higher raw material costs" squeezing margins, despite the record quarter. The gross-margin figures support that reading in part, since the −0.8 percentage points decline came even as operating margin improved because operating expenses grew more slowly than revenue. Protolabs' own filing explains what the business did in the quarter; it does not explain why the shares moved.
Free cash flow is falling faster than earnings
Trailing-twelve-month free cash flow fell 28.2% even as net income rose 136.0% over the same period, a gap that has opened as cash generation and reported profit move in different directions. The trailing free cash flow margin now stands at 8.4%, down 4.7 percentage points from a year earlier. In our discounted cash flow model, a one percentage point fall in FCF margin leaves modeled value per share down 10.8%, and if the past year's margin decline persists, model value is down 33.5%. Growth matters too, though less than margin on this scale: a stage-one growth assumption five points below the current base case of 11.8% would leave model value down 22.1%, while five points above it would leave model value up 28.6%. Under base-case assumptions that include this quarter's reported trends, we calculate a value per share of $48.00. These are model values under stated assumptions, not a comparison with the share price.
For the balance sheet and margin history behind these figures, see our full company analysis.
The fourth-quarter test
Protolabs guided to fourth-quarter revenue of $143.0 million to $151.0 million and GAAP diluted earnings per share of $0.28 to $0.36. If gross margin stabilises near the 44.5% reported this quarter while operating margin keeps expanding, that would support the view that higher input costs are being absorbed rather than eroding the business. A fourth-quarter gross margin that falls further, even if revenue and operating margin both still improve, would support the raw material cost explanation for the reaction over the valuation-reassessment reading.